Potential protection from toxicity by oral iron chelators

被引：41
|
作者：
Hider, RC
机构：
[1] Department of Pharmacy, King's College London, London, SW3 6LX, Manresa Road
来源：
TOXICOLOGY LETTERS | 1995年 / 82-3卷
关键词：
iron chelators; oral activity; metalloenzymes; hydroxypyridinones; cell cycle;
D O I：
10.1016/0378-4274(95)03606-7
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
The design of clinically useful iron chelators requires attention to be paid to 3 key parameters: oral absorption, selectivity and affinity for iron(III) and toxicity. Factors which influence these 3 parameters are discussed. Hydroxypyridinones are identified as key ligands and properties leading to minimal toxicity and optimum distribution for the treatment of thalassaemia are presented. Key metalloenzymes which are inhibited by iron chelators are identified.
引用
收藏
页码：961 / 967
页数：7
相关论文
共 50 条
  • [21] Iron chelators as mitophagy agents: Potential and limitations
    Brogyanyi, Tereza
    Kejik, Zdenek
    Vesela, Katerina
    Dytrych, Petr
    Hoskovec, David
    Masarik, Michal
    Babula, Petr
    Kaplanek, Robert
    Pribyl, Tomas
    Zelenka, Jaroslav
    Ruml, Tomas
    Vokurka, Martin
    Martasek, Pavel
    Jakubek, Milan
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 179
  • [22] Oral iron chelators: new opportunities and new dilemmas
    Hershko, Chaim
    HAEMATOLOGICA, 2006, 91 (10) : 1307 - 1312
  • [23] ORAL IRON CHELATORS - PROSPECTS FOR FUTURE-DEVELOPMENT
    PORTER, J
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1989, 43 (04) : 271 - 285
  • [24] Evaluation of new iron chelators and their therapeutic potential
    Aouad, F
    Florence, A
    Zhang, Y
    Collins, F
    Henry, C
    Ward, RJ
    Crichton, RR
    INORGANICA CHIMICA ACTA, 2002, 339 : 470 - 480
  • [25] Iron chelators from mycobacteria (1954-1999) and potential therapeutic applications
    Vergne, AF
    Walz, AJ
    Miller, MJ
    NATURAL PRODUCT REPORTS, 2000, 17 (01) : 99 - 116
  • [26] Synthesis of 2-alkyl-3-hydroxy-4-pyridinone-ribonucleosides, potential oral iron chelators
    Liu, G
    Bruenger, FW
    Barrios, AM
    Miller, SC
    NUCLEOSIDES & NUCLEOTIDES, 1995, 14 (9-10): : 1901 - 1904
  • [27] Oral iron chelators and the treatment of iron overload in pediatric patients with chronic anemia
    Vichinsky, Elliott
    PEDIATRICS, 2008, 121 (06) : 1253 - 1256
  • [28] ORAL IRON CHELATORS FOR THE CLINICAL MANAGEMENT OF IRON OVERLOAD - CURRENT HOPES AND PROBLEMS
    PIOMELLI, S
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 612 : 311 - 314
  • [29] Potential multidentate therapeutic iron chelators: Synthesis and iron complex stability
    Jurchen, KMC
    Xu, JD
    Raymond, KN
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U37 - U37
  • [30] Therapeutic potential of iron chelators in retinal vascular diseases
    Li, Yan
    Cheng, Zi-Xuan
    Luo, Ting
    Lyu, Hong-Bin
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2023, 16 (11) : 1899 - 1910
12345